tirzepatide 0.25 mg Injectable – 25 mg/mL Mounjaro Weight Loss Injections –
Description
A Phase 2 trial published in The New England Journal of Medicine in 2023 enrolled 338 adults with obesity
Hazard ratio (HR) e odds ratio (OR) : misure di rischio relativo
They postulate the pain felt by patients is out of proportion to the damage seen, the pain is not just because cartilage over the bone gets worn down. They state the thin rim of the cartilage becomes inflamed and sends pain signals to the body
Participants remained in-house for a minimum of 72 h after dosing (Fig
Healthcare visits are increased by 50% in such patients, with absenteeism and lowered workplace productivity
